Search research articles
Contact Us
Filters
Showing results (121-130 of 159) with videos related to
Page
of 16
Sort By:
Annals of Neurology
|
April 18, 2026
Use of Machine Learning to Identify Markers of Risk for Fragile X-Associated Tremor/Ataxia Syndrome: A Preliminary Analysis
Chitrabhanu Gupta, Angeela Poudel, Jun Yi Wang, et al.
Brain Sciences
|
September 16, 2020
Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
Skylar Luu, Haley Province, Elizabeth Berry-Kravis, et al.
World Journal of Clinical Pediatrics
|
November 19, 2025
Parallel paths: A narrative review exploring autism and its co-occurring conditions
Hasan Hasan, Randi Hagerman, Daphne S Say, et al.
Journal of Neurodevelopmental Disorders
|
April 23, 2020
Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome
Angela John Thurman, Laura A Potter, Kyoungmi Kim, et al.
The Journal of Molecular Diagnostics : JMD
|
July 5, 2011
FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles
David E Godler, Howard R Slater, Quang M Bui, et al.
Clinical Genetics
|
September 19, 2024
Knowledge and perceptions about fragile X syndrome and fragile X-premutation-associated conditions among medical doctors in Nigeria
Chioma N P Mbachu, Randi Hagerman, Edwin Eseigbe, et al.
The Yale Journal of Biology and Medicine
|
December 31, 2021
Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?
Dragana Protic, Maria Jimena Salcedo-Arellano, Maja Stojkovic, et al.
Brain : a Journal of Neurology
|
April 23, 2010
Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome
John M Olichney, Shiaohui Chan, Ling M Wong, et al.
Journal of Neurodevelopmental Disorders
|
June 16, 2017
Arbaclofen in fragile X syndrome: results of phase 3 trials
Elizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, et al.
Neuroscience and Biobehavioral Reviews
|
November 14, 2006
Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X
Danuta Z Loesch, Quang M Bui, Cheryl Dissanayake, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 159) with videos related to
Sort By:
Page
of 16
Annals of Neurology
|
April 18, 2026
Use of Machine Learning to Identify Markers of Risk for Fragile X-Associated Tremor/Ataxia Syndrome: A Preliminary Analysis
Chitrabhanu Gupta, Angeela Poudel, Jun Yi Wang, et al.
Brain Sciences
|
September 16, 2020
Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
Skylar Luu, Haley Province, Elizabeth Berry-Kravis, et al.
World Journal of Clinical Pediatrics
|
November 19, 2025
Parallel paths: A narrative review exploring autism and its co-occurring conditions
Hasan Hasan, Randi Hagerman, Daphne S Say, et al.
Journal of Neurodevelopmental Disorders
|
April 23, 2020
Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome
Angela John Thurman, Laura A Potter, Kyoungmi Kim, et al.
The Journal of Molecular Diagnostics : JMD
|
July 5, 2011
FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles
David E Godler, Howard R Slater, Quang M Bui, et al.
Clinical Genetics
|
September 19, 2024
Knowledge and perceptions about fragile X syndrome and fragile X-premutation-associated conditions among medical doctors in Nigeria
Chioma N P Mbachu, Randi Hagerman, Edwin Eseigbe, et al.
The Yale Journal of Biology and Medicine
|
December 31, 2021
Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?
Dragana Protic, Maria Jimena Salcedo-Arellano, Maja Stojkovic, et al.
Brain : a Journal of Neurology
|
April 23, 2010
Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome
John M Olichney, Shiaohui Chan, Ling M Wong, et al.
Journal of Neurodevelopmental Disorders
|
June 16, 2017
Arbaclofen in fragile X syndrome: results of phase 3 trials
Elizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, et al.
Neuroscience and Biobehavioral Reviews
|
November 14, 2006
Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X
Danuta Z Loesch, Quang M Bui, Cheryl Dissanayake, et al.
Page
of 16